EVRA 203 micrograms/24 hours + 33.9 micrograms/24 hours transdermal patch *
Pharmacy Only: Prescription

Updated on 29 June 2022

File name

62bc7f3a64878.pdf

Reasons for updating

  • Change to section 4.3 - Contraindications
  • Change to section 4.4 - Special warnings and precautions for use
  • Change to section 4.5 - Interaction with other medicinal products and other forms of interaction
  • Change to section 4.8 - Undesirable effects
  • Change to section 5.2 - Pharmacokinetic properties
  • Change to section 10 - Date of revision of the text

Legal category:Product subject to medical prescription which may be renewed (B)

Updated on 29 June 2022

File name

62bc7d6b062a2.pdf

Reasons for updating

  • Change to section 2 - what you need to know - contraindications
  • Change to section 2 - what you need to know - warnings and precautions
  • Change to section 4 - possible side effects

EDM Updated on 04 November 2021

File name

Information sheet for women - IE Gedeon Richter FINAL (3)_1636038976.pdf

Reasons for updating

  • Add New Doc

EDM Updated on 04 November 2021

File name

CHC prescriber-checklist - IE Gedeon Richter FINAL (3)_1636038944.pdf

Reasons for updating

  • Add New Doc

Updated on 04 November 2021

File name

IE_Evra_203 mcg-24h+33.9mcg-24h_trd_patch_SmPC_1636038534.pdf

Reasons for updating

  • New SPC for new product

Legal category:Product subject to medical prescription which may be renewed (B)

Updated on 04 November 2021

File name

IE_Evra_203 mcg-24h+33.9mcg-24h_trd_patch_PIL_1636038503.pdf

Reasons for updating

  • New PIL for new product